Showing results (251-260 of 954) with videos related to
Sort By:
Pageof 96
Clinical & Developmental Immunology|March 26, 2011
Diverse roles of inhibitor of differentiation 2 in adaptive immunityLucille Rankin, Gabrielle T BelzClinical & Developmental Immunology|May 24, 2011
The M. tuberculosis phosphate-binding lipoproteins PstS1 and PstS3 induce Th1 and Th17 responses that are not associated with protection against M. tuberculosis infectionCarla Palma, Ralf Spallek, Giovanni Piccaro, et al.Clinical & Developmental Immunology|June 8, 2011
Antigen-based immune therapeutics for type 1 diabetes: magic bullets or ordinary blanks?Slobodan Culina, Christian Boitard, Roberto MalloneClinical & Developmental Immunology|June 8, 2011
Type I diabetes-associated tolerogenic properties of interleukin-2Aziz Alami Chentoufi, Simon Gaudreau, Alex Nguyen, et al.Clinical & Developmental Immunology|October 21, 2011
The inhibitory role of b7-h4 in antitumor immunity: association with cancer progression and survivalChangjun He, Haiquan Qiao, Hongchi Jiang, et al.Clinical & Developmental Immunology|October 21, 2011
Tumor and microenvironment modification during progression of murine orthotopic bladder cancerSin Mun Tham, Kee Hui Ng, Sim Hwee Pook, et al.Clinical & Developmental Immunology|October 21, 2011
Indirect effects of oral tolerance inhibit pulmonary granulomas to Schistosoma mansoni eggsGeraldo Magela Azevedo, Raquel Alves Costa, Mariana Araujo Resende, et al.Clinical & Developmental Immunology|November 24, 2011
The development of severe neonatal alloimmune thrombocytopenia due to anti-HPA-1a antibodies is correlated to maternal ABO genotypesMaria Therese Ahlen, Anne Husebekk, Mette Kjær Killie, et al.Clinical & Developmental Immunology|November 24, 2011
The tumor necrosis factor superfamily of cytokines in the inflammatory myopathies: potential targets for therapyBoel De Paepe, Kim K Creus, Jan L De BleeckerClinical & Developmental Immunology|October 5, 2011
Adaptive immunity in ankylosing spondylitis: phenotype and functional alterations of T-cells before and during infliximab therapyBalázs Szalay, Gergo Mészáros, Áron Cseh, et al.Pageof 96